Genetic variations in DNA synthesis gene Rpa3 have been associated with susceptibility to carcinomas [51], whereas increased cancer expression of Rpa2 is associated with adverse outcome in colon cancer [52]. Here, RPA3 is linked to malignant colon neoplasm.